RxDoctor Payments Data

Kimberly Grill, DO

Internal Medicine · St Petersburg, FLNPI 1902816606

Payments from drug & device makers

$141in general payments, 2019–2025

Across 9 payments — averaging $15.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Exact Sciences$59
  • Novo Nordisk$31
  • Scilex Pharmaceuticals Inc.$15
  • Pfizer$12
  • Sunovion Pharmaceuticals Inc.$12
  • Johnson & Johnson$11

What the payments were for

  • Food & beverage$141100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$141 in reported general payments places this provider in the 30th percentile of 8,530 internal medicine providers in Florida.

See all internal medicine providers in Florida

Medicare billing

Part B allowed, 2024
$158,424
Medicare patients
292
Services billed
2,283

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide117$135,646
EliquisApixaban58$58,148
XareltoRivaroxaban32$51,519
JardianceEmpagliflozin32$46,663
JanuviaSitagliptin Phosphate33$37,046
MigergotErgotamine Tartrate/Caffeine13$29,729
TradjentaLinagliptin26$24,578
ProliaDenosumab14$24,407
MyrbetriqMirabegron22$21,558
TrulicityDulaglutide14$20,483
Trelegy ElliptaFluticasone/Umeclidin/Vilanter18$17,912
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog12$10,789
MounjaroTirzepatide11$10,781
Victoza 3-PakLiraglutide11$6,542
Lantus SolostarInsulin Glargine,hum.Rec.Anlog47$5,170

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$31$135,646117 claims
PfizerEliquis$12$58,14858 claims
Johnson & JohnsonXarelto$11$51,51932 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 30th percentile of 8,530 internal medicine providers in Florida.

Other internal medicine in St Petersburg

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →